Literature DB >> 21482918

Amyloid-dependent and amyloid-independent stages of Alzheimer disease.

Bradley T Hyman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21482918     DOI： 10.1001/archneurol.2011.70

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  90 in total

Review 1.  Testing the right target and right drug at the right stage.

Authors:  Reisa A Sperling; Clifford R Jack; Paul S Aisen
Journal:  Sci Transl Med       Date:  2011-11-30       Impact factor: 17.956

2.  Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.

Authors:  John C Morris
Journal:  Arch Neurol       Date:  2012-06

3.  Toward a multifactorial model of Alzheimer disease.

Authors:  Martha Storandt; Denise Head; Anne M Fagan; David M Holtzman; John C Morris
Journal:  Neurobiol Aging       Date:  2012-01-20       Impact factor: 4.673

4.  CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade.

Authors:  Nikki H Stricker; Hiroko H Dodge; N Maritza Dowling; S Duke Han; Elena A Erosheva; William J Jagust
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

5.  Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects.

Authors:  Steven P Millard; Franziska Lutz; Ge Li; Douglas R Galasko; Martin R Farlow; Joseph F Quinn; Jeffrey A Kaye; James B Leverenz; Debby Tsuang; Chang-En Yu; Elaine R Peskind; Lynn M Bekris
Journal:  Neurobiol Aging       Date:  2013-09-04       Impact factor: 4.673

Review 6.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

7.  Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology.

Authors:  Philip S Insel; Niklas Mattsson; R Scott Mackin; Michael Schöll; Rachel L Nosheny; Duygu Tosun; Michael C Donohue; Paul S Aisen; William J Jagust; Michael W Weiner
Journal:  Neurology       Date:  2016-04-15       Impact factor: 9.910

8.  Cognitive deficits and disruption of neurogenesis in a mouse model of apolipoprotein E4 domain interaction.

Authors:  Samuel O Adeosun; Xu Hou; Baoying Zheng; Craig Stockmeier; Xiaoming Ou; Ian Paul; Thomas Mosley; Karl Weisgraber; Jun Ming Wang
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

9.  Brain injury biomarkers are not dependent on β-amyloid in normal elderly.

Authors:  David S Knopman; Clifford R Jack; Heather J Wiste; Stephen D Weigand; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Rosebud O Roberts; Bradley F Boeve; Ronald C Petersen
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

10.  Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.

Authors:  Stephen N Gomperts; Joseph J Locascio; Dorene Rentz; Andrea Santarlasci; Marta Marquie; Keith A Johnson; John H Growdon
Journal:  Neurology       Date:  2012-12-12       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.